Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence, Mol. Microbiol, vol.72, pp.85-97, 2009. ,
Partial saturation of menaquinone in Mycobacterium tuberculosis: function and essentiality of a novel reductase, MenJ. ACS Cent. Sci, vol.1, pp.292-302, 2015. ,
Allosteric regulation of menaquinone (vitamin K 2 ) biosynthesis in the human pathogen Mycobacterium tuberculosis, J. Biol. Chem, vol.295, pp.3759-3770, 2020. ,
Structural views along the Mycobacterium tuberculosis MenD reaction pathway illuminate key aspects of thiamin diphosphate-dependent enzyme mechanisms, Structure, vol.24, pp.1167-1177, 2016. ,
Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis, PLoS ONE, vol.14, 2019. ,
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study, Lancet Respir. Med, vol.5, pp.269-281, 2017. ,
Drug sensitivity and environmental adaptation of mycobacterial cell wall components, Trends Microbiol, vol.4, pp.275-281, 1996. ,
MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis, Med. Chem, vol.5, pp.197-207, 2009. ,
A novel smallmolecule inhibitor of the Mycobacterium tuberculosis demethylmenaquinone methyltransferase MenG is bactericidal to both growing and nutritionally deprived persister Cells, vol.8, pp.2022-2038, 2017. ,
Novel MenA inhibitors are bactericidal against Mycobacterium tuberculosis and synergize with electron transport chain inhibitors, Antimicrob. Agents Chemother, vol.63, pp.3771-3772, 2019. ,
, J. Biol. Chem